Evidence map›Paper›PMID 42645613›Full record

ReviewCurrent cardiology reports2026

Recent Advances in SPECT Myocardial Perfusion Tracers: Tc-99m-4BOH.

Yufan Gu, Wanjie Ren, Wei Fang, Lei Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yufan GuDepartment of Nuclear Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 167 Beilishi Road, Beijing, 100037, China.
Wanjie RenDepartment of Nuclear Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 167 Beilishi Road, Beijing, 100037, China.
Wei FangDepartment of Nuclear Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 167 Beilishi Road, Beijing, 100037, China. nuclearfw@126.com.
Lei WangDepartment of Nuclear Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, 167 Beilishi Road, Beijing, 100037, China. leiwangfw@126.com.ORCID https://orcid.org/0000-0003-0273-6129

Funding

Beijing Nova Program 20230484328National High Level Hospital Clinical Research Funding 2024-GSP-TJ-2National Key Research and Development Program of China 2024YFF0507704
6 · The paper itself

Abstract

purpose of reviewThis review traces the rationale behind the development of the novel myocardial perfusion tracer RECENT

findingsPreclinical and first-in-human studies demonstrated that

Indexed as

Myocardial Perfusion ImagingOrganotechnetium CompoundsRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonAnimalsHumansTechnetium Tc 99m SestamibiOrganotechnetium CompoundsRadiopharmaceuticalsTechnetium Tc 99m Sestamibi99mTc(III) novel radiotracerBlood flow quantificationMyocardial perfusion imagingSPECT

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.